ROYAL BANK OF CANADA - PYXIS ONCOLOGY INC ownership

PYXIS ONCOLOGY INC's ticker is and the CUSIP is 747324101. A total of 52 filers reported holding PYXIS ONCOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of PYXIS ONCOLOGY INC
ValueSharesWeighting
Q2 2024$100,000
-8.3%
30,193
+17.9%
0.00%
Q1 2024$109,000
+5350.0%
25,600
+2586.3%
0.00%
Q4 2023$2,000
-66.7%
953
-70.9%
0.00%
Q3 2023$6,000
-93.8%
3,273
-91.3%
0.00%
Q2 2023$96,000
-67.0%
37,675
-48.1%
0.00%
Q1 2023$291,00072,545
+37683.9%
0.00%
Q3 2022$0
-100.0%
192
-70.6%
0.00%
Q1 2022$3,000
-87.0%
653
-69.4%
0.00%
Q4 2021$23,0002,1360.00%
Other shareholders
PYXIS ONCOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
SUPERSTRING CAPITAL MANAGEMENT LP 484,443$1,603,5062.02%
STEMPOINT CAPITAL LP 1,202,675$3,980,8541.17%
Blue Owl Capital Holdings LP 1,046,025$3,462,3430.96%
Ikarian Capital, LLC 1,662,408$5,502,5710.96%
Deep Track Capital, LP 4,184,100$13,849,3710.41%
Decheng Capital LLC 326,810$1,081,7410.33%
Yu Fan 69,303$229,3930.30%
Cable Car Capital LLC 61,606$203,9160.22%
Ikarian Capital, LLC 3,586$1,186,9660.21%
Laurion Capital Management LP 3,861,179$12,780,5020.15%
View complete list of PYXIS ONCOLOGY INC shareholders